Highlight

Labtec announces

Labtec and GSK finalize license agreement >>

TRANSDERMAL SYSTEMS (TDS)

A specific dose of medication delivered through the skin

A transdermal patch or transdermal system (TDS) is a medicated adhesive patch that is placed on the skin to deliver a specific dose of drug through the skin and into the bloodstream. >>

ORAL DISSOLVABLE FILMS (ODF)

Oral film technology: an innovative form of oral medication

Labtec's Rapidfilm®, a proprietary oral film technology, is an innovative oral dosage form that combines the application ease of a liquid with the stability and dosing accuracy of a tablet. >>

SERVICES

Let our experience be your benefit

We can explore the feasibility of a full development program and assess a program’s chances of success. >>

DIRECT CONTACT

Fon: +49 (2173) 9735-0
Fax: +49 (2173) 9735-35

PRESS CENTER

06/21/10

Labtec and GSK finalize license agreement for an innovative topical patch to treat cold sores

GlaxoSmithKline acquired the exclusive marketing rights for a new topical patch for the treatment of cold sores from Labtec. >>

03/23/10

European Approval of Ondansetron Rapidfilm®

APR Applied Pharma Research s.a. and Labtec GmbH announce the European Approval of Ondansetron Rapidfilm®, co-developed in partnership with MonoSol Rx and licensed to BioAlliance Pharma SA for EU countries. >>

10/06/09

“An important role in our business with the pharmaceutical industry”

Interview with Joachim Suesse, Head of the Business Unit tesa Health Markets >>